The research of the clinical effect for high-dose ulinastatin small on the SIRS and patients with MODS
10.3760/cma.j.issn.1008-6706.2013.01.019
- VernacularTitle:大剂量乌司他丁治疗全身炎症反应综合征及合并多器官功能障碍综合征的临床研究
- Author:
Guoliang REN
- Publication Type:Journal Article
- Keywords:
Ulinastatin;
Sepsis syndrome;
Multiplc organ failure
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(1):47-49
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical effect of large dose ulinastatin on patients combined SIRS and MODS.Methods 120 patients in ICU were randomly divided into two groups,each 60 cases,the control group using conventional standard treatment,the observation group in the control group on the basis of the 12h after the operation started on intravenous injection of large dose ulinastatin,observe two groups of patients after treatment with cytokine content and duration of hospital stay,mortality rate and APACHE Ⅱ score after treatment.Results The two groups before treatment TNFα,IL-6,IL-8 and APACHE Ⅱ score difference is not big,after treatment,48 h,72 h,two groups of patients with TNFα,IL-6,IL-8 were decreased,and the observation group decreased greater than the control group (t =8.46,8.72,8.68,10.38,7.83,9.26,all P ＜ 0.05),after treatment the observation group APACHE Ⅱ score,mortality,average time of hospitalization were significantly lower than those of the control group,there was statistical significance(t =9.58,x2 =10.28,t =9.17,all P ＜ 0.05).Conclusion High dose ulinastatin on inflammatory cytokines have obvious inhibition effect,can reduce the surgical risk in patients with APACHE Ⅱ score and mortality,shorten the treatment time of patients.
